SEVIKAR

This brand name is authorized in Austria, Australia, Germany, Spain, Finland, France, Ireland, Italy, Netherlands, Romania, Tunisia, Turkey, United Kingdom

Active ingredients

The drug SEVIKAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Olmesartan medoxomil UNII 6M97XTV3HD - OLMESARTAN MEDOXOMIL

Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations. Read about Olmesartan medoxomil

2 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SEVIKAR Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DB02	Olmesartan medoxomil and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5292M, 5293N, 5294P
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 04712677, 04712683, 04712714, 04712720, 05515826, 06115365, 06115371, 06115388, 07117722, 07117739, 07117745, 07117774, 07117780, 07117797, 07117828, 07117834, 07117840, 07515664, 07517166, 07517284, 07770238, 07770273, 07770304, 07773171, 07773188, 08871243, 09338930, 09340217, 10005984, 10005990, 11322959, 12670131, 13907581, 16200505, 17184837, 17185305, 17185311, 17584703, 17584726, 17584732, 17584749, 17584755, 17584761, 17620592
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 038983161, 038983247, 70069, 70072, 70079
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 169484, 169495, 169506, 169517, 169528, 169539
Country: FR	Base de données publique des médicaments	Identifier(s): 64127633, 64954736, 67023718
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 157727, 157730, 157733, 374209
Country: IT	Agenzia del Farmaco	Identifier(s): 038983021, 038983161, 038983247
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 88005, 88013, 88021
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68064001, W68064002, W68064003, W68064004, W68064005, W68064006, W68064007, W68064008, W68064009, W68064010, W68064011, W68065001, W68065002, W68065003, W68065004, W68065005, W68065006, W68065007, W68065008, W68065009, W68065010, W68065011, W68066001, W68066002, W68066003, W68066004, W68066005, W68066006, W68066007, W68066008, W68066009, W68066010, W68066011
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12803051, 12803052, 12803053
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699228090096, 8699228090102, 8699228090119